[What has changed in therapy of vascular patients (role of statins and beta-adrenoblockers)].
作者信息
Pokrovskiĭ A V, Goloviuk A L
出版信息
Angiol Sosud Khir. 2010;16(2):7-11.
PMID:21032867
Abstract
Systematised herein are the results of large-scale randomized studies, as well as own findings regarding the use of beta-adrenoblockers and statins in vascular patients. Administration of selective beta-adrenoblockers and statins appeared to decrease the cardiac-complication rate in this cohort of patients.
摘要
相似文献
1
[What has changed in therapy of vascular patients (role of statins and beta-adrenoblockers)].
Angiol Sosud Khir. 2010;16(2):7-11.
2
[Should the treatment of diabetic dyslipidemia be modified after the Action to Control Cardiovascular Risk in Diabetes Lipid study?].糖尿病血脂异常的治疗在糖尿病血脂控制心血管风险行动研究后是否应进行调整？
Endocrinol Nutr. 2010 Dec;57(10):457-9. doi: 10.1016/j.endonu.2010.05.010. Epub 2010 Aug 4.
3
[Statins in practice of the vascular surgeon and cardiologist].[血管外科医生和心脏病专家实践中的他汀类药物]
Angiol Sosud Khir. 2009;15(2):123-7.
4
Heart protection study finds simvastatin reduces vascular risk in a wide range of high-risk patients.
Am J Manag Care. 2002 Jan;Suppl:6.
5
[SBU should investigate what is an evidence-based and cost-effective use of statins].战略业务单元应调查他汀类药物基于证据且具成本效益的使用方式。
Lakartidningen. 2009;106(32-33):1992-4.
6
Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.依折麦布与他汀类药物联合使用治疗男性和女性高胆固醇血症时疗效和安全性的一致性。
J Womens Health (Larchmt). 2004 Dec;13(10):1101-7. doi: 10.1089/jwh.2004.13.1101.
7
Statins in threatened stroke.
Stroke. 2003 Feb;34(2):351-3. doi: 10.1161/01.str.0000054260.05136.7d.
8
[Substantiation of increasing doses of statins in clinical practice].[临床实践中他汀类药物剂量增加的依据]
Ter Arkh. 2001;73(4):76-80.
9
[Treatment of chronic heart failure. The time of statins?].
Kardiologiia. 2005;45(12):4-10.
10
[Treatment with statins for the reduction of cardiovascular risk].
Ital Heart J Suppl. 2001 Mar;2(3):221-3.
Zotero 插件